![]()
MIRA INFORM
REPORT
|
Report Date : |
30.01.2012 |
Trans-Medica Pharma Handelsgesellschaft mbH & Co. KG
Company Status: active
Main address:
Neuer Wall 77
D 20354 Hamburg
Telephone:040/355422-0
Telefax: 040/346977
Homepage: www.transmedica.de
E-mail:
office@transmedica.de
Business
relations are permissible.
LEGAL FORM Ltd
partnership with priv. ltd. company as
general partner
Date of foundation: 1978
Registered on: 15.05.1996
Register of
companies: Local
court 20355 Hamburg
under: HRA
89673
EUR 250,533.02
Karl-Peter Schäcke
Kuhkoppel 13
D 21521 Aumühle
born: 26.06.1939
Share: EUR 250,533.02
General partner:
PM Pharma-Marketing Import + Export GmbH
Nöpps 41
D 22043 Hamburg
Legal form: Private limited company
Share capital: EUR 25,564.59
Registered on: 14.03.2008
Reg. data: 20355 Hamburg, HRB 104570
Shareholder:
Karl-Peter Schäcke
Kuhkoppel 13
D 21521 Aumühle
born: 26.06.1939
Share: EUR 25,564.59
Manager:
Jens Schäcke
Hemmingstedter Weg 158
D 22609 Hamburg
having sole power of representation
born: 12.07.1943
Profession: Businessman
Marital status: married
Manager:
Karl-Peter Schäcke
Kuhkoppel 13
D 21521 Aumühle
having sole power of representation
born: 26.06.1939
Profession: Businessman
15.05.1996 -
10.07.1996 Trans-Medica
Pharma-Handelsgesellschaft
mbH
Büschstr. 12
D
20354 Hamburg
Private limited company
26.08.1997 -
01.04.1998 Trans-Medica Pharma
Handelsgesellschaft
mbH & Co. KG
Büschstr. 12
D
20354 Hamburg
Ltd partnership with priv. ltd. company
as
general partner
Sectors
46461 Wholesale of pharmaceutical goods
46902 Non-specialized
wholesale of raw materials and half-finished and finished goods
Payment experience: within periods customary in this trade
Negative information:We
have no negative information at hand.
Maximum credit: 44,000 EUR
Balance sheet year: 2010
Type of ownership: Tenant
Address Neuer Wall 77
D
20354 Hamburg
Land register documents
were not available.
Principal
bank
BERENBERG, JOH. - GOSSLER
& CO, HAMBURG
Sort. code: 20120000, BIC:
BEGODEHHXXX
Gross profit or loss:2010 EUR 2,600,000.00
2011 EUR 2,600,000.00
further
business figures:
Equipment: EUR 60,000.00
Ac/ts receivable: EUR 1,304,508.00
Liabillities: EUR 2,135,008.00
Employees: 10
The aforementioned business
figures may partly be estimated
information based on
average values in the line of business.
Balance sheet ratios 01.01.2010 - 31.12.2010
Equity ratio [%]: 12.42
Liquidity ratio: 2.68
Balance sheet grade: 3.5
Balance sheet ratios 01.01.2009 - 31.12.2009
Equity ratio [%]: 10.66
Liquidity ratio: 10.00
Balance sheet grade: 3.6
Balance sheet ratios 01.01.2008 - 31.12.2008
Equity ratio [%]: 10.54
Liquidity ratio: 10.00
Balance sheet grade: 3.1
Balance sheet ratios 01.01.2007 - 31.12.2007
Equity ratio [%]: 27.96
Liquidity ratio: 10.00
Return on total capital [%]: 16.51
Balance sheet grade: 2.0
Equity ratio
The equity ratio indicates
the portion of the equity as compared
to the total capital. The
higher the equity ratio, the better the
economic stability
(solvency) and thus the financial autonomy of
a company.
Liquidity ratio
The liquidity ratio shows
the proportion between adjusted
receivables and net
liabilities. The higher the ratio, the lower
the company's financial
dependancy from external creditors.
Return on total capital
The return on total capital
shows the efficiency and return on
the total capital employed
in the company. The higher the return
on total capital, the more
economically does the company work
with the invested capital.
Balance sheet grade
The balance sheet grade is
based on the following ratios: equity
ratio, liquidity ratio and
return on total capital from the
balance sheets published in
the Federal Gazette.
Type
of balance
sheet: Company balance sheet
Financial year: 01.01.2010 - 31.12.2010
ASSETS EUR 3,463,660.74
Fixed assets
EUR 56,252.00
Tangible assets EUR 56,252.00
Other / unspecified tangible assets
EUR 56,252.00
Current assets
EUR 3,395,521.99
Stocks
EUR 442,917.43
Accounts receivable
EUR 1,304,508.21
Other debtors and assets
EUR 1,304,508.21
Liquid means
EUR 1,648,096.35
Remaining other assets
EUR 11,886.75
Accruals (assets)
EUR 11,886.75
LIABILITIES EUR 3,463,660.74
Shareholders' equity
EUR 430,045.99
Capital
EUR 430,045.99
Capital of the fully liable partner
(LP, general partnership)
EUR 179,512.97
Capital contribution of gen.
partner/accounts of the pers. liable
shareholder
EUR 179,512.97
Limited partner's capital / capital
of partially liable partner (LP)
EUR 250,533.02
Provisions
EUR 898,606.60
Liabilities
EUR 2,135,008.15
Other liabilities
EUR 2,135,008.15
Unspecified other liabilities
EUR 2,135,008.15
Type
of balance
sheet: Company balance sheet
Financial year: 01.01.2009 - 31.12.2009
ASSETS EUR 3,949,137.50
Fixed assets
EUR 28,227.00
Tangible assets
EUR 28,227.00
Other / unspecified tangible assets
EUR 28,227.00
Current assets
EUR 3,911,820.44
Stocks
EUR 456,246.35
Accounts receivable
EUR 944,834.21
Other debtors and assets
EUR 944,834.21
Liquid means EUR 2,510,739.88
Remaining other assets
EUR 9,090.06
Accruals (assets)
EUR 9,090.06
LIABILITIES EUR 3,949,137.50
Shareholders' equity
EUR 420,824.35
Capital
EUR 420,824.35
Capital of the fully liable partner
(LP, general partnership)
EUR 250,533.02
Capital contribution of gen.
partner/accounts of the pers. liable
shareholder
EUR 250,533.02
Limited partner's capital / capital
of partially liable partner (LP)
EUR 170,291.33
Provisions
EUR 1,082,263.00
Liabilities
EUR 2,446,050.15
Other liabilities
EUR 2,446,050.15
Unspecified other liabilities
EUR 2,446,050.15
MIRA INFORM
REPORT
|
Report Date : |
30.01.2012 |
|
|
|
IDENTIFICATION DETAILS
|
Correct Name : |
TRANS-MEDICA PHARMA
HANDELSGESELLSCHAFT MBH |
|
|
|
|
Registered Office : |
Neuer Wall 77, D 20354 Hamburg |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2009 |
|
|
|
|
Date of Incorporation : |
15.05.1996 |
|
|
|
|
Com. Reg. No.: |
HRA 89673 |
|
|
|
|
Legal Form : |
Ltd Partnership With Priv. Ltd. Company as General Partner |
|
|
|
|
Line of Business : |
Wholesale of Pharmaceutical Goods |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
EUR 34.000 |
|
Status : |
Satisfactory |
|
Payment
Behaviour : |
Regular |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2010
|
Country Name |
Previous Rating (01.04.2010) |
Current Rating (30.06.2010) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Trans-Medica
Pharma Handelsgesellschaft mbH & Co. KG
Neuer Wall 77
D 20354 Hamburg
Telephone:040/355422-0
Telefax: 040/346977
Homepage: www.transmedica.de
E-mail: office@transmedica.de
Business relations are permissible.
LEGAL FORM Ltd
partnership with priv. ltd. company as general partner
Date of foundation :1978
Registered on :15.05.1996
Register of companies :
Local court 20355 Hamburg
Under :
HRA 89673
Total cap. Contribution :
EUR 250.533,02
Karl-Peter Schäcke
Kuhkoppel 13
D 21521 Aumühle
born: 26.06.1939
Share: EUR 250.533,02
PM Pharma-Marketing Import + Export GmbH
Nöpps 41
D 22043 Hamburg
Legal form : Private limited
company
Share capital : EUR
25.564,59
Registered on : 14.03.2008
Reg. Data : 20355
Hamburg, HRB 104570
Karl-Peter Schäcke
Kuhkoppel 13
D 21521 Aumühle
born: 26.06.1939
Share:EUR 25.564,59
Jens Schäcke
Hemmingstedter Weg 158
D 22609 Hamburg
having sole power of representation
born: 12.07.1943
Profession: Businessman
Marital status: married
Manager:
Karl-Peter Schäcke
Kuhkoppel 13
D 21521 Aumühle
having sole power of representation
born: 26.06.1939
Profession: Businessman
15.05.1996 - 10.07.1996 Trans-Medica
Pharma-Handelsgesellschaft mbH
Büschstr. 12
D 20354 Hamburg
Private limited
company
26.08.1997 - 01.04.1998 Trans-Medica Pharma
Handelsgesellschaft mbH & Co. KG
Büschstr. 12
D 20354 Hamburg
Ltd partnership
with priv. ltd. Company as general partner
Sectors
46461 Wholesale of
pharmaceutical goods
46902 Non-specialized
wholesale of raw materials and half-finished and finished goods
Payment experience :within
periods customary in this trade
Negative information :We
have no negative information at hand.
Maximum credit :34.000
EUR
Balance sheet year: 2009
Type of ownership: Tenant
Address Neuer Wall 77
D 20354 Hamburg
Land register documents were not available.
Principal bank
BERENBERG, JOH. - GOSSLER & CO, HAMBURG
Sort. code: 20120000, BIC: BEGODEHHXXX
Gross profit or loss :2009 EUR 2.600.000,00
2010 EUR 2.600.000,00
further business figures :
Employees :
10
The aforementioned business figures may partly be estimated
information based on average values in the line of business.
Balance sheet ratios 2009
Equity ratio [%] :
10,66
Liquidity ratio :
10,00
Balance sheet ratios 2008
Equity ratio [%] :
10,54
Liquidity ratio :
10,00
Balance sheet ratios 2007
Equity ratio [%] : 27,96
Liquidity ratio :
10,00
Return on total capital [%] :
16,51
Equity ratio
The equity ratio indicates the portion of the equity as compared
to the total capital. The higher the equity ratio, the better the economic stability
(solvency) and thus the financial autonomy of a company.
Liquidity ratio
The liquidity ratio shows the proportion between adjusted
receivables and net liabilities. The higher the ratio, the lower the company's
financial dependancy from external creditors.
Return on total
capital
The return on total capital shows the efficiency and return on the
total capital employed in the company. The higher the return on total capital,
the more economically does the company work with the invested capital.
Type of balance
sheet: Company balance sheet
Financial year: 01.01.2009 - 31.12.2009
ASSETS EUR 3.949.137,50
Fixed assets
EUR 28.227,00
Tangible assets
EUR 28.227,00
Other / unspecified tangible assets
EUR 28.227,00
Current assets
EUR 3.911.820,44
Stocks
EUR 456.246,35
Accounts receivable
EUR 944.834,21
Other debtors and assets
EUR 944.834,21
Liquid means
EUR 2.510.739,88
Remaining other assets
EUR 9.090,06
Accruals (assets)
EUR 9.090,06
LIABILITIES EUR 3.949.137,50
Shareholders' equity
EUR 420.824,35
Capital EUR 420.824,35
Capital of the fully liable partner
(LP, general partnership)
EUR 250.533,02
Capital contribution of gen.
partner/accounts of the pers. liable
shareholder EUR
250.533,02
Limited partner's capital / capital
of partially liable partner (LP)
EUR 170.291,33
Provisions
EUR 1.082.263,00
Liabilities
EUR 2.446.050,15
Other liabilities
EUR 2.446.050,15
Unspecified other liabilities
EUR 2.446.050,15
Type of balance
sheet: Company balance sheet
Financial year: 01.01.2008 - 31.12.2008
ASSETS EUR 3.906.143,68
Fixed assets
EUR 45.400,50
Tangible assets
EUR 45.400,50
Current assets
EUR 3.860.743,18
Stocks
EUR 732.081,21
Accounts receivable
EUR 893.256,80
Liquid means
EUR 2.235.405,17
LIABILITIES EUR 3.906.143,68
Shareholders' equity
EUR 411.731,56
Capital
EUR 411.731,56
Capital of the fully liable partner
(LP, general partnership)
EUR 161.198,54
Capital contribution of gen.
partner/accounts of the pers. liable
shareholder
EUR 161.198,54
Limited partner's capital / capital
of partially liable partner (LP)
EUR 250.533,02
Provisions
EUR 1.347.247,00
Liabilities EUR 2.147.165,12
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.49.64 |
|
|
1 |
Rs.77.79 |
|
Euro |
1 |
Rs.65.05 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Company |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.